BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 5, 2021
View Archived Issues
Identification of a vitamin D3 analogue inducing SREBP degradation without calcemic action
Read More
Results of phase I dose-escalation study of MVC-COV-1901 SARSCoV-2 vaccine candidate
Read More
ALICE study data support iadademstat with azacitidine in acute myeloid leukemia
Read More
Washington University reports dosimetry data for brain PET radiotracer [11C]CS1P1
Read More
Arrowhead voluntarily pauses phase I/II study of ARO-ENaC in CF
Read More
Sanofi initiates early clinical studies of SAR-444245
Read More
Genzyme patents new CFTR modulators
Read More
Omeros divulges new MASP2 inhibitors
Read More
Chinese researchers identify new CDK9 inhibitors
Read More
Sichuan Haisco Pharmaceutical identifies new ENPP2 inhibitors
Read More
Intestinal MYC modulates weight-related metabolic dysfunction
Read More
Beijing Tuojie Biopharmaceutical patents CaSR agonists
Read More
Initiation of phase II trial of Hepalatide in chronic hepatitis B
Read More
Amgen starts phase I study of AMG-609 in NAFLD
Read More
Pluripotent stem cell-derived CECs for the treatment of corneal dystrophies
Read More
Patient enrollment begins in phase II study of ADR-001 in severe pneumonia due to COVID-19
Read More
Sperogenix to develop Abbisko's ABSK-021 for rare neurological diseases in China
Read More
GNT-0003 restores UGT1A1 expression in patients with Crigler-Najjar syndrome
Read More
Phase Ib data presented for ulixertinib plus palbociclib in advanced solid tumors
Read More
SHR-1314 studied in phase II/III trial for active ankylosing spondylitis
Read More
Initiation of phase II study of HA-121-28 in advanced biliary tract cancer
Read More
Transcenta reports antitumor responses with TST-001 in gastric cancer
Read More
DPP3 is a marker of severity in heart failure
Read More